Demo Sign up Log In

Vertex Pharmaceuticals (VRTX)

Income Tax Expense

$292.00M

Quarterly · Period ending: Jun 30, 2026 · USD

VRTX Income Tax Expense

Latest reported$292.00Mperiod endingJun 30, 2026

Latest reported$292.00Mperiod endingJun 30, 2026

VRTX Quarterly Income Tax ($0.00 → $292.00M)

Quarterly income tax expense

High-resolution chart · PNG

VRTX income tax expense history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Vertex Pharmaceuticals Income Tax Expense — Quarterly (USD)
Period ending	Income Tax Expense (USD)
Jun 30, 2001	0
Mar 31, 2001	-6,525,000
Dec 31, 2000	-3,147,000
Sep 30, 2000	9,686,000
Jun 30, 2000	-3,161,000
Mar 31, 2000	-2,402,000
Dec 31, 1999	400,000
Sep 30, 1999	400,000
Jun 30, 1999	400,000
Mar 31, 1999	-2,800,000
Dec 31, 1998	300,000
Sep 30, 1998	200,000
Jun 30, 1998	200,000
Mar 31, 1998	-3,900,000
Dec 31, 1997	300,000
Sep 30, 1997	200,000
Jun 30, 1997	200,000
Mar 31, 1997	200,000
Dec 31, 1996	-1,600,000
Sep 30, 1996	-1,100,000
Jun 30, 1996	0
Mar 31, 1996	-1,100,000
Dec 31, 1995	1,500,000
Sep 30, 1995	-1,100,000
Jun 30, 1995	-1,300,000
Mar 31, 1995	-1,200,000
Dec 31, 1994	-3,500,000
Sep 30, 1994	200,000
Jun 30, 1994	100,000
Mar 31, 1994	0
Dec 31, 1993	-100,000
Sep 30, 1993	-200,000
Jun 30, 1993	200,000
Mar 31, 1993	-200,000
Dec 31, 1992	200,000
Sep 30, 1992	-400,000
Jun 30, 1992	-400,000
Mar 31, 1992	-500,000
Dec 31, 1991	0
Sep 30, 1991	-200,000
Jun 30, 1991	100,000
Mar 31, 1991	0
Dec 31, 1990	0
Sep 30, 1990	0
Jun 30, 1990	0
Mar 31, 1990	0

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.